221 related articles for article (PubMed ID: 34512202)
21. Molecular Characterization of TFE3-Rearranged Renal Cell Carcinoma: A Comparative Study With Papillary and Clear Cell Renal Cell Carcinomas.
Wei S; Krause HB; Geynisman DM; Elliott A; Kutikov A; Uzzo RG; Pei J; Barata P; Carneiro B; Heath E; Ryan C; Farrell A; Nabhan C; Ali-Fehmi R; Naqash AR; Argani P; McKay RR
Mod Pathol; 2024 Feb; 37(2):100404. PubMed ID: 38104891
[TBL] [Abstract][Full Text] [Related]
22. Non-coding RNA and gene expression analyses of papillary renal neoplasm with reverse polarity (PRNRP) reveal distinct pathological mechanisms from other renal neoplasms.
Nemours S; Armesto M; Arestín M; Manini C; Giustetto D; Sperga M; Pivovarcikova K; Pérez-Montiel D; Hes O; Michal M; López JI; Lawrie CH
Pathology; 2024 Jun; 56(4):493-503. PubMed ID: 38413252
[TBL] [Abstract][Full Text] [Related]
23. Incidence of Clear Cell Papillary Renal Cell Carcinoma in Low-Grade Renal Cell Carcinoma Cases: A 12-Year Retrospective Clinicopathologic Study From a Single Cancer Center.
Gill S; Kauffman EC; Kandel S; George S; Schwaab T; Xu B
Int J Surg Pathol; 2016 May; 24(3):207-12. PubMed ID: 26510859
[TBL] [Abstract][Full Text] [Related]
24. Genetic Underpinnings of Renal Cell Carcinoma With Leiomyomatous Stroma.
Parilla M; Alikhan M; Al-Kawaaz M; Patil S; Kadri S; Ritterhouse LL; Segal J; Fitzpatrick C; Antic T
Am J Surg Pathol; 2019 Aug; 43(8):1135-1144. PubMed ID: 30986793
[TBL] [Abstract][Full Text] [Related]
25. GATA3 as a valuable marker to distinguish clear cell papillary renal cell carcinomas from morphologic mimics.
Mantilla JG; Antic T; Tretiakova M
Hum Pathol; 2017 Aug; 66():152-158. PubMed ID: 28705707
[TBL] [Abstract][Full Text] [Related]
26. Clear-cell papillary renal cell tumour: New insights into clinicopathological features and molecular landscape after renaming by 5th WHO classification.
Zhang W; Zhang L; Wen Z; Liang J; Wang Y; Wang Z; Yin Z; Fan L
Pathol Res Pract; 2024 Mar; 255():155167. PubMed ID: 38324963
[TBL] [Abstract][Full Text] [Related]
27. Clear cell papillary renal cell carcinoma - An indolent subtype of renal tumor.
Chen WJ; Pan CC; Shen SH; Chung HJ; Lin CC; Lin ATL; Chang YH
J Chin Med Assoc; 2018 Oct; 81(10):878-883. PubMed ID: 30037497
[TBL] [Abstract][Full Text] [Related]
28. "Renal Cell Carcinoma With Leiomyomatous Stroma" Harbor Somatic Mutations of TSC1, TSC2, MTOR, and/or ELOC (TCEB1): Clinicopathologic and Molecular Characterization of 18 Sporadic Tumors Supports a Distinct Entity.
Shah RB; Stohr BA; Tu ZJ; Gao Y; Przybycin CG; Nguyen J; Cox RM; Rashid-Kolvear F; Weindel MD; Farkas DH; Trpkov K; McKenney JK
Am J Surg Pathol; 2020 May; 44(5):571-581. PubMed ID: 31850909
[TBL] [Abstract][Full Text] [Related]
29. Tumor grade estımatıon of clear cell and papıllary renal cell carcınomas usıng contrast-enhanced MDCT and FSE T2 weıghted MR ımagıng: radıology-pathology correlatıon.
Halefoglu AM; Ozagari AA
Radiol Med; 2021 Sep; 126(9):1139-1148. PubMed ID: 34100169
[TBL] [Abstract][Full Text] [Related]
30. Histologic subtype needs to be considered after partial nephrectomy in patients with pathologic T1a renal cell carcinoma: papillary vs. clear cell renal cell carcinoma.
Yoo S; You D; Jeong IG; Song C; Hong B; Hong JH; Ahn H; Kim CS
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1845-1851. PubMed ID: 28451753
[TBL] [Abstract][Full Text] [Related]
31. Preservation of truncal genomic alterations in clear cell and papillary renal cell carcinomas with sarcomatoid features: An intra- and intertumoral, multifocal fluorescence in situ hybridization analysis reveals limited genetic heterogeneity.
Sanfrancesco JM; Eble JN; Grignon DJ; Wang M; Zhang S; Sundaram CP; Idrees MT; Pili R; Kouba E; Cheng L
Mol Carcinog; 2017 Nov; 56(11):2527-2537. PubMed ID: 28667776
[TBL] [Abstract][Full Text] [Related]
32. Screening and identification of key biomarkers of papillary renal cell carcinoma by bioinformatic analysis.
Xu Y; Kong D; Li Z; Qian L; Li J; Zou C
PLoS One; 2021; 16(8):e0254868. PubMed ID: 34358255
[TBL] [Abstract][Full Text] [Related]
33. Validation of 34betaE12 immunoexpression in clear cell papillary renal cell carcinoma as a sensitive biomarker.
Martignoni G; Brunelli M; Segala D; Munari E; Gobbo S; Cima L; Borze I; Wirtanen T; Sarhadi VK; Atanesyan L; Savola S; Barzon L; Masi G; Fassan M; Eble JN; Bohling T; Cheng L; Delahunt B; Knuutila S
Pathology; 2017 Jan; 49(1):10-18. PubMed ID: 27923499
[TBL] [Abstract][Full Text] [Related]
34. Update on selected renal cell tumors with clear cell features. With emphasis on multilocular cystic clear cell renal cell carcinoma.
Montironi R; Mazzucchelli R; Scarpelli M; Lopez-Beltran A; Cheng L
Histol Histopathol; 2013 Dec; 28(12):1555-66. PubMed ID: 23893851
[TBL] [Abstract][Full Text] [Related]
35. Papillary renal cell carcinoma: a clinicopathological and whole-genome exon sequencing study.
Liu K; Ren Y; Pang L; Qi Y; Jia W; Tao L; Hu Z; Zhao J; Zhang H; Li L; Yue H; Han J; Liang W; Hu J; Zou H; Yuan X; Li F
Int J Clin Exp Pathol; 2015; 8(7):8311-35. PubMed ID: 26339402
[TBL] [Abstract][Full Text] [Related]
36. Diagnostic and prognostic tissuemarkers in clear cell and papillary renal cell carcinoma.
Kroeze SG; Bijenhof AM; Bosch JL; Jans JJ
Cancer Biomark; 2010; 7(6):261-8. PubMed ID: 21694464
[TBL] [Abstract][Full Text] [Related]
37. TCEB1-mutated renal cell carcinoma: a distinct genomic and morphological subtype.
Hakimi AA; Tickoo SK; Jacobsen A; Sarungbam J; Sfakianos JP; Sato Y; Morikawa T; Kume H; Fukayama M; Homma Y; Chen YB; Sankin A; Mano R; Coleman JA; Russo P; Ogawa S; Sander C; Hsieh JJ; Reuter VE
Mod Pathol; 2015 Jun; 28(6):845-853. PubMed ID: 25676555
[TBL] [Abstract][Full Text] [Related]
38. Expression of parafibromin in clear cell papillary renal cell carcinoma.
Cui C; Ziober A; Bing Z
Appl Immunohistochem Mol Morphol; 2013 Jul; 21(4):322-5. PubMed ID: 23060304
[TBL] [Abstract][Full Text] [Related]
39. Papillary renal cell carcinoma with a somatic mutation in MET in a patient with autosomal dominant polycystic kidney disease.
Zhang W; Tan AY; Blumenfeld J; Liu G; Michaeel A; Zhang T; Robinson BD; Salvatore SP; Kapur S; Donahue S; Bobb WO; Rennert H
Cancer Genet; 2016; 209(1-2):11-20. PubMed ID: 26718059
[TBL] [Abstract][Full Text] [Related]
40. Papillary renal cell carcinoma: analysis of germline mutations in the MET proto-oncogene in a clinic-based population.
Lindor NM; Dechet CB; Greene MH; Jenkins RB; Zincke MT; Weaver AL; Wilson M; Zincke H; Liu W
Genet Test; 2001; 5(2):101-6. PubMed ID: 11551094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
